Tag: Featured Story

Employee turnover isn’t just a staffing headache. It’s also a profit leak. In cannabis retail, where compliance mistakes and customer trust both carry real financial weight, losing a seasoned budtender means losing margin. In today’s industry, retention belongs in the revenue conversation, not the personnel file. Stable teams sell more, make fewer errors, and build repeat customers no marketing budget can buy. The operators who treat workforce stability as infrastructure, not overhead, are the ones quietly outperforming their markets.

In an increasingly competitive landscape, “good enough” is no longer a sustainable business strategy. As cannabis transitions into a true consumer packaged good, the contrast between patchwork processes and precision systems has never been more consequential. Scaling isn’t just about producing more; it’s about producing consistently. Ed Wells examines the critical role of data-driven tools in cultivation and post-harvest operations. His conclusion? Embracing operational rigor is not a departure from cannabis culture, but the essential evolution needed to protect craftsmanship while ensuring long-term success at scale.

For years, Sarah Strickler kept her professional life in the cannabis industry separate from her role as a mother, weighed down by the “smell of judgment.” In this Mother’s Day op-ed, the Grown Rogue co-founder reflects on the 600-percent increase in incarcerated women since the 1980s and the double standards mothers face. Strickler argues that building a responsible industry requires more than transparency; it requires active repair, expungement support, and creating a future where the next generation inherits responsibility and pride rather than the heavy burden of legacy stigma.

The move to reschedule cannabis is facing its first major judicial test. Following a lawsuit by Smart Approaches to Marijuana (SAM), the industry is left wondering if the shift to Schedule III is in jeopardy. While the April 23 order remains in effect for now, the legal challenge introduces new layers of uncertainty for medical and adult-use operators alike. To maintain stability, companies must look beyond the headlines. We break down the two critical factors that will determine whether federal relief arrives on time or hits a roadblock.

Federal rescheduling may reshape banking, taxes, and research, but it won’t reset the race for AI‑driven brand visibility. The real shift happened earlier, as AI engines began concentrating citations on the few cannabis brands that published structured, state‑specific, credentialed content at scale. Those early movers now benefit from compounding authority that Schedule III reform cannot unwind. As consumer prompts evolve toward medical access and Schedule III language, the brands already producing that content are widening their lead. The math is unforgiving: Visibility accrues to the prepared.

As the cannabis market matures, dispensaries are discovering the over-40 demographic prioritizes a specific set of retail values: clarity, education, and transparency. Moving beyond the flashy marketing and high-potency hype that often defines the industry, these shoppers seek out environments where they feel respected and informed. Winning their loyalty requires a shift toward education-led selling, where budtenders act as knowledgeable guides rather than high-pressure salespeople. From the importance of easily accessible lab results to the necessity of a navigable retail environment, these are the essential pillars for building long-term trust with this growing and influential consumer segment.

Why aren’t cannabis basket sizes growing despite a constant influx of new products? Retail expert Wendy Milne explains why adding more high-THC SKUs is often a recipe for market stagnation and how “light” cannabis — products designed for moderation and social functionality — is driving a significant increase in average transaction value. By analyzing data from the Ontario Cannabis Store and Lite Label partners, Milne reveals 58 percent of consumers are actively seeking lower-potency options. Here’s how to reframe the “weak” stigma into a premium social-use case that builds loyalty and captures incremental growth in a saturated market.

The DEA has launched a portal for state-licensed medical cannabis registration, offering a rare path to federal legitimacy. However, with House Republicans moving to bottle up broader rescheduling and a 60-day window closing fast, operators face both a race for federal protection and an increasingly uncertain climate in D.C.

While the federal reclassification of cannabis to Schedule III is being hailed as a historic milestone, for dispensary owners, the “victory” comes with a complex set of operational strings attached. From the selective application of 280E tax relief to the slow-moving evolution of the banking sector, the transition is more about precision than celebration. This guide breaks down why the “medical lane” is the new front line of profitability, how to audit your revenue streams for upcoming tax shifts, and why compliance documentation is now more critical than ever.

The Department of Justice moving cannabis from Schedule I to Schedule III is a historic shift, but it isn’t a universal fix. From the multi-million-dollar 280E tax opportunity to the ongoing hurdles for adult-use operators, we break down the real business impact of the 2026 rescheduling order and why federal oversight is about to get a lot more complex.